Kronox Lab shares got listed at 21% premium. What should investors do?
Kronox Lab Sciences witnessed a decent listing at the bourses on Monday with a 21% premium over the issue price. Even though it is a positive start, the debut fell short of pre-listing expectations, fuelled by the initially high grey market premium (GMP) that had declined steadily in the days leading up to the listing. … Read more
